Form 8-K - Current report:
SEC Accession No. 0001558370-22-014879
Filing Date
2022-10-06
Accepted
2022-10-06 16:05:22
Documents
13
Period of Report
2022-10-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20221005x8k.htm   iXBRL 8-K 35653
  Complete submission text file 0001558370-22-014879.txt   241758

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20221005.xsd EX-101.SCH 3247
3 EX-101.LAB aytu-20221005_lab.xml EX-101.LAB 632
4 EX-101.PRE aytu-20221005_pre.xml EX-101.PRE 10404
7 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20221005x8k_htm.xml XML 4866
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 221298211
SIC: 2834 Pharmaceutical Preparations